A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
A phase 2 trial of PF-08634404, Bevacizumab, CAPOX in colorectal cancer, run by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., now recruiting.
Overview
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients is a phase 2 interventional study registered as NCT06493760 by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., with 130 participants planned, started 2024-09-03 and due to reach its primary completion in 2025-06. Interventions recorded: SSGJ-707, Bevacizumab, Oxaliplatin, Capecitabine, Calcium Folinate. Conditions listed: Metastatic Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialNeoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Capecitabine, Colorectal cancer.
- TrialA Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Can
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Bevacizumab, Colorectal cancer.
- TrialBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Shares Capecitabine, Bevacizumab, Colorectal cancer.
- TrialA Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Bevacizumab, Colorectal cancer.
- TrialA Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Shares Leucovorin (folinic acid), Capecitabine, Bevacizumab.
- TrialA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Shares Leucovorin (folinic acid), Bevacizumab, Colorectal cancer.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Leucovorin (folinic acid), Capecitabine.